Since 1947, the specialists at lege artis Pharma GmbH + Co. KG have been working to provide dentists and patients with high-quality products that help maintain dental and oral health. The company's motto has been just as long:
For dentists who work according to lege artis,( meaning "the rules of the art") .
When the company founder Johann Pfandl founded lege artis dental trading company in Austria in 1947, he could already look back on more than 15 years of experience in the dental and general medical field.
With great creativity and diligence, he developed the first range of pharmaceutical specialties for dental use, including the well-known TOXAVIT, the first and still well-established devitalization agent in the world.
After relocating the company headquarters to Germany, the son of the company founder, Mr. Mag. Pharm. Kurt Pfandl, responsible for the product range, which he specifically expanded. He developed numerous new drugs, including products such as FOKALMIN, SOCKETOL and LEGASED.
After taking over the company, he initiated the construction of new business premises in Dettenhausen, near the university town of Tübingen, in 1972. As early as 1981 the business building was expanded to include a new production wing and additional storage rooms.
Lege artis Pharma became known as a specialist in dental pharmaceuticals and the distribution of the products was established even beyond the borders of Europe. Further modernizations and extensions of the company building followed in 1994, 2007, 2010 and 2014.
Today's managing director, Dr. Brigitte Bartelt, granddaughter of the company founder, joined the company in 1993 and took over management in 1997. Committed and prudent, she led the company to certification according to DIN EN ISO 9001 and 46001 or DIN EN ISO 13485 and RL 93/42 / EEC, thus creating the prerequisites for the development, manufacture and marketing of the new product class of dental medical products.
Further measures such as the modernization of the corporate identity, intensification of the advertising area and the development of new products such as HYPOSEN, CALCINASE-slide or CALCIPRO consolidated the success of the family company.